baber/WOPTO huggingface dataset:
Patent CS-235575-B1 (CS)
Inventor: FUSKA JAN
IPC: C07G99/00
Filed: 1983-08-19
Abstract: Vynález sa týká nového metabolitu získaného
biotransformáciou withaferinu A.
Podstata metabolitu podía vynálezu spočívá
v tom, že je pripravitelný přidáním 10
až 100 ml withaferinu A alebo withaferinu
A diacetátu k 100 ml média naočkovaného
kulturou Rothrobacter simplex ATCC 6946
a kultivovaného pri teplote 25 až 32 °C počas
26 až 120 hodin.
Metabolit podía vynálezu v pokusoch in
vitro inhibuje biochemické reakeie a rast
buniek P 388 a v pokusoch in vivo inhibuje
rast nádorov.
Patent CS-268631-B1 (CS)
Inventor: POTESIL TOMAS ING CSC
IPC: C07H15/18
Filed: 1988-10-20
Abstract: Příprava 1,2-0-isopropyliden-3,5,6-
-tri-O-benzyl-alfa_D—glukofuranózy pro
farmaceutické a Jiné účely benzylací
1,2-O-isopropyliden-aLfa-D-glukofuranózy,
Tato látka se rozpustí v xylenu,
přidá se vodný roztok hydroxidu alkalického
kovu a benzylchlorid a směs se
refluxuje při 135 až 140 °C po dobu
200 až 220 minut. Reakčni voda se odstraňuje
ve formě azeotropu s xylenem. Vyloučené
soli se odstraní vymiohánim
s vodou a produkt se izoluje oddestilovánim
xylenu za sníženého tlaku.
Patent CS-252767-B1 (CS)
Inventor: JANOUSEK PAVEL
IPC: B65G47/16
Filed: 1985-09-28
Abstract: Tlumící štít v presypu pásového dopravníku je upevněný na ocelové konstrukci poháněči stanice pomocí nosníku. Na nosníku je uchycen střední díl tlumicího štítu, ke kterému je pomocí horních čepů připevněn horní díl tlumicího štítu, o- vládaný hydraulickým válcem upevněným na příčníku. Pomocí spodních čepů je ke střednímu dílu tlumicího štítu připevněn dolní díl tlumicího štítu, ovládaný spodním hydraulickým válcem upevněným na příčníku . Na nosníku je upevněn křížový čep k natáčení středního dílu tlumicího štítu
Patent CS-253920-B1 (CS)
Inventor: TRUCHLIK STEFAN
IPC: C07D209/48
Filed: 1985-10-10
Abstract: Riešenie sa týká sposobu přípravy O,O-dimetyl-S-ftalimidometylditiofosfátu
dvojstup­
ňovým prebytkom reagujúcich zložiek alkalickej
alebo amónnej soli kyseliny 0,0-dimetylditiofosforečnej
a N-chlórmetylftalimidu.
Riešenie je možné využit v chemickom priemysle,
pri výrobě insekticídne účinnej zlú-
čeniny
Patent CS-213170-B1 (CS)
Inventor: VANCL JOSEF
IPC: G03G5/08
Filed: 1980-11-04
Abstract: Materiál je tvořen kysličníkem zinečnatým,
dielektriokým nosným médiem a přísadami a
funkcí stabilizátorů. Použitý kysličník
zlnečnatý je charakterizován poměrem intenzit
luminiscence v UV a viditelné oblasti,
přičenž tato hodnota činí minimálně
1. Celkový podíl použitého kysličníku
zinečnatého může být vytvořen jako směs
dvou nebo více typů rozdílných fyzikálních
a chemidkých vlastností, přičemž poměr
intenzit luminiscence v UV a viditelné
oblasti eměei odpovídá dané hodnotě.
Patent CS-261690-B1 (CS)
Inventor: JANOSKO MILAN ING
IPC: F16F9/346
Filed: 1987-10-17
Abstract: Rieši sa usporiadanie mechanizmu pre vyvodenie
tlmiaceho účinku a reguláciu jeho
velkosti.
jeho podstatou je převedeme tlmiča, ktoré
je tvořené telesom s tvarovou drážkou,
krúžkom oddelujúcim pracovný tlakový priestor
od nízkotlakového priestoru· a škrtiacim
elementom spojeným buď s piestom, připadne
s piestnicou. Piestníca ukončená nárazníkem
je prostredníctvom vodiacehio člena
posuvno spojená s regulačným elementom.
Počas pohybu je piestnica vedená bud
piestom, alebo je posuvné uložená v ložisku
upevnenom v medzikuse tlmiča.
Uvedený mechanizmus tlmenia můžeme
použil všade tam, kde je potřebné tlmiť kinetickú
energiu pohybujúcich sa hmůt, například
narážkové systémy priemyselných
robotov a manipulátorov. Vhodným usporiadaním
tvarovej drážky v telese tlmiča
možno dosiahnuf 1'uhovol'ný priebeh pracovnej
charakteristiky tlmiča
Patent CS-229371-B1 (CS)
Inventor: CMEJLA PETR
IPC: G06F7/68
Filed: 1982-11-01
Abstract: Vynález se týká obvodů pro číslicové po- t
čítání a řeáí obvod kontinálního součinu
dvou frekvencí. Obvod je tvořen progra- . movatelným děličem frekvence, k jehož ί
předvolbě je připojen obvod pro vyhodno- t , cování délky periody jedné z obou násobených
frekvencí. Ze programovatelným děličem
frekvence jsou připojeny výstupní H
©bvody pro zablokování výstupu při činnosti
celého obvodu v nežádoucím rozsahu
násobených frekvencí.
Patent CS-244261-B1 (CS)
Inventor: ILIEV STOJAN A
IPC: H01L21/70
Filed: 1984-11-22
Abstract: Řešení se týká kontaktovací elektrody,
u níž je keramická hmota po obou
stranách opatřena první vrstvou niklu Ni
a na jedné její straně je na první vrstvu
niklu Ni nanesena druhá vrstva hliní­
ku Al, zatímco na druhé straně keramické
hmoty je na první vrstvu niklu Ni nanesena
třetí vrstva mědi Cu nebo zlata Au.
Použitím se dosáhne úspor až 100 % u drahých
kovů, čip je levnější a spolehlivější.
Je vhodná pro všechny typy hybridních
integrovaných obvodů.
Patent CS-230481-B1 (CS)
Inventor: ZIGMUND JOSEF
IPC: H03K3/00
Filed: 1982-12-17
Abstract: Signál taktovacího kmitočtu se sinusovým
průběhem se přivádí přes oddělovací
kondenzátor na bázi tranzistoru,který
pracuje jako laděný zesilovač s paralelním
rezonančním obvodem. K zesílenému
vstupnímu signálu se v kolektorovém obvodu
přičítá stejnosměrné napětí vznikající
na první a druhé diodě. Stejnosměrná
složka výsledného signálu leží uprostřed
vstupních úrovní hradla. Na výstupu
hradla jsou taktovaci impulsy se střídou
1:1. Diody zaručují správnou teplotní
kompensaci hradla.
Patent CS-265918-B1 (CS)
Inventor: BOREK JAROSLAV
IPC: F27D3/02
Filed: 1986-12-18
Abstract: Cílem je řešení kombinované tepelné
izolace vodou chlazených trubek, skluznic
a jejich příčných trubkových podpěr používaných
v ohřívacích a narážecích pecích se
spodním ohřevem v hutních válcovnách. Izolace
sestává z první vrstvy vláknitého
keramického materiálu obtočeného okolo
vodou chlazené ocelové trubky, která je
svou vnější plochou přilepena nánosem
lepicího tmelu k vnitřnímu povrchu plechové
armatury, na níž je obtočena druhá vrstva
vláknitého keramického materiálu, jejíž
vnější povrch je obdusán žáruvzdornou
plastickou hmotou. K vnějšímu povrchu
plechové armatury jsou připevněny trny
s kotevními podložkami ve dvou délkových
odstupech
Patent DK-175073-B1 (DK)
Inventor: CHEN KAU-MING
IPC: C07D209/10
Filed: 1990-06-13
Granted: 2004-05-24
Abstract: Compounds of formula Iare disclosedwhereinXis -CH₂CH₂- or -CH=CH;R₁is an ester group inert to the reaction conditions; andRis an organic radical having groups which are inert under reducing conditions, with the proviso that, when R is triphenylmethyl, then R₁ additionally includes allyl and X is -OCH₂-or the free acid or a salt form or a further ester form or the δ-lactone, i.e. internal ester form thereof, in a state of purity such that the proportion of erythro to threo isomer is 99:1 : 0.9 or higher.
Patent DK-172949-B1 (DK)
Inventor: BARRIERE JEAN-CLAUDE
IPC: C07K7/06
Filed: 1987-05-21
Granted: 1999-10-11
Abstract: The invention provides new synergistin derivatives of formula <IMAGE>  (I)  in which Y is hydrogen or dimethylamino and R is a 3- or 4-quinuclidinyl radical, the isomers thereof and their mixtures, and their salts, also the preparation thereof. These compounds may be made by reaction of the corresponding 5-methylene compounds with the appropriate mercaptoquinuclidine. The products of formula (I), optionally combined with pristinamycin IIA or a derivative of pristinamycin IIB of the formula    <IMAGE> (II)  are useful as antimicrobials.
Patent DK-174400-B1 (DK)
Inventor: BORSTEL REID WARREN VON
IPC: A61K8/00
Filed: 1989-06-27
Granted: 2003-02-10
Abstract: Use of acyl derivatives of deoxyribonucleosides in manufacture of a medicament for enhancing haematopoesis or enhancing healing of bone marrow. <IMAGE>
Patent FI-101476-B1 (FI)
Inventor: ESMON CHARLES T
IPC: C12P21/08
Filed: 1990-08-29
Granted: 1998-06-30
Abstract: A Ca<2+> dependent monoclonal antibody that specifically binds to a specific twelve peptide sequence (E D Q V D P R L I D G K) in the activation region of the protein C. The antibody does not bind to activated protein C and can be used to inhibit activation of protein C by thrombin-thrombomodulin. The antibody can be isolated from cell culture or ascites fluid in large quantities by affinity chromatography with mild conditions using the peptide bound to an immobilized substrate. The antibody has a number of specific uses in isolation and characterization of protein C and as a model for the design of Ca<2+> dependent antibodies for the isolation of other proteins, as a diagnostic, and as a therapeutic to prevent activation of protein C. The protein c can be naturally produced or produced by expression of the recombinant gene. Advantages of the antibody in purification of protein C include the specificity for protein C and not activated protein C, and the unique Ca<2+>-peptide binding specificity which allows the binding site to be protected when it is being immobilized on the chromatographic support. In vivo, the antibody has been demonstrated to inhibit tumor growth. The antibody can also be used to promote clotting in patients having high levels of Factor VIII inhibitors.
Patent IE-32304-B1 (IE)
Title: Improvements in or relating to lattice girders for reinforcing concrete panels and the like structures
IPC: E04C/
Filed: 1968-08-26
Abstract: 1,189,071. Wire fabrics. BAU-STAHLGEWEBE G.m.b.H. 19 Aug., 1968 [24 Aug., 1957], No. 39573/68. Heading D1K. A wire fabric for reinforcing concrete or the like comprises a mat of longitudinal wires 1, 2 joined by transverse wires 3 at an acute angle to the longitudinal axis, which is bent about axis C-C. The mat is also bent about axes A-A to provide supports. The wires 2 may be fixed above or below the transverse wires. Several mats may be integrally constructed, and separated before bending.
[GB1189071A]
Patent IE-46901-B1 (IE)
Title: Improvements in and relating to apparatus for hanging an article
IPC: E05B69/00
Filed: 1978-05-24
Abstract: This invention relates to apparatus for hanging an article having an aperture therein, such as a garment having a sleeve. According to the invention there is provided a carrier for carrying the article, an elongate flexible member suspended at one end portion thereof from the carrier and securing means for securing together the carrier and an end portion of the flexible member. The arrangement is such that when an article is carried by the carrier with the flexible member threaded through the sleeve thereof and with the securing means securing together the carrier and the flexible member, the article is restrained from being removed from the carrier. The carrier may be used with a stand having a blocking bar for presenting removal of a carrier supported therefrom or the carrier may be provided with a hook for mounting on a stand.
Patent IE-35582-B1 (IE)
Title: A thioester and method of preparing same
IPC: C07C327/30
Filed: 1971-08-31
Abstract: 1320256 Azetidinones and cephalosporins ELI LILLY & CO 9 Sept 1971 [10 Sept 1970] 42179/71 Headings C2A and C2C Novel, therapeutic compounds (I) and (II) where A is phthalimido or RCONH-, R is H, ethoxycarbonyl, or C 1-8 alkyl, C 3-8 cycloalkyl or C 2-8 alkenyl optionally substituted with OH, SH, C 1-3 -alkoxy or -alkylthio or CN, or is a group of Formula (III), (IV) or (V) where Q is H, OH, SH, Cl, Br, C 1-3 -alkyl, -alkoxy or -alkylthio, NO 2 or CN, X is O, S or a direct bond, Y is OH, SH or NH 2 , m is 0, 1 or 2, n is 1 or 2, R<SP>1</SP> is -CH 2 OZ, -CH 2 O.CO.Z, -CONHZ or -CO 2 R<SP>11</SP> where R<SP>11</SP> is C 1-4 alkyl, C 4-6 tert-alkyl, C 5-8 tertalkenyl or -alkynyl, benzyl, methoxybenzyl, nitrobenzyl, benzhydryl, phthalimidomethyl, succinimidomethyl, phenacyl or trichloroethyl, Z is H, C 1-8 alkyl, C 3-8 cycloalkyl, or C 2-8 alkanyl, optionally substituted with OH, SH, C 1-3 -alkoxy or -alkylthio or CN or Z is phenyl or phenyl-C 1-3 -alkyl optionally substituted with OH, SH, Cl, Br, C 1-3 -alkyl, -alkoxy or -alkylthio, NO 2 or CN and W is Me, Et, Pr or Ph, are made by treating (VI) with triphenyl phosphine or trialkyl phosphite in the presence of acetic, propionic, butyric or benzoic anhydride (I is obtained; it is converted to the isomer II by treatment with base). Cephalosporins (VII) are obtained by oxidizing (I) or (II); (VII) can be dehydrated to give the corresponding unsaturated compound.
[GB1320256A]
Patent IE-65952-B1 (IE)
Title: Crystalline human proinsulin and process for its production
Inventor: JACKSON RICHARD LEE
IPC: C07K14/62
Filed: 1988-04-20
Abstract: Human proinsulin in crystalline form which comprises a salt of a complex of human proinsulin and divalent zinc ion, the cation of said salt being selected from the group consisting of lithium, calcium, sodium, potassium, ammonium, magnesium, and barium. The preparation comprises (a) preparing an aqueous mixture containing from about 5 to about 50 mg/ml human proinsulin, from about 0.1 to about 5 mg/ml of a phenolic substance, from about 0.03 to about 0.6 milliequivalents/ml of a salt of a cation selected from the group consisting of lithium, calcium, sodium, potassium, ammonium, magnesium, and barium, and from about 0.2 to about 5 milliequivalents of Zn<+><2> cation; (b) adjusting the aqueous mixture to a pH in the range of from about 5.4 to about 6.5; (c) allowing crystal formation to occur; and (d) recovering crystalline human proinsulin from the aqueous mixture.
Patent IE-35692-B1 (IE)
Title: A process for the enzyme scission of lactose of milk and derivatives of same and the products obtained thereby
Inventor: DINELLI D
IPC: C12N11/04
Filed: 1971-10-05
Abstract: 1359666 Milk products SNAM PROGETTI SpA 18 Oct 1971 [17 Oct 1970] 48439/71 Heading A2B [Also in Division C3] A process for the enzymatic scission of lactose in milk or a derivative of milk comprising contacting the milk or derivative of milk with a filament in which is present the enzyme #-galactosidase, the #-galactosidase being present in the filament in a manner such that it can cause the at least partial hydrolysis of lactose and is retained substantially in the filament during hydrolysis. The enzyme may be incorporated in a filament formed from a cellulose derivative or a synthetic polymer. The cellulose derivative may be cellulose triacetate (Ex 1) whilst the polymer may be a polyamide, polyacrylonitrile, a polyacrylate, a polymethacrylate, a polyvinylchloride, a polyvinylester or a polyvinylbutyral. The enzymatic reaction may be intercalated by a washing operation with a detergent which optionally contains a bactericide. The composition produced by the process comprises milk or a derivative thereof, having a reduced concentration of lactose, and an amount of glucose and galactose corresponding to the reduction in lactose concentration, and free or substantially free of enzymatic agent. The milk may be partially skimmed, concentrated milk or whey.
[GB1359666A]
Patent IE-55526-B1 (IE)
Title: Air-cathode button cell
IPC: H01M12/06
Filed: 1984-06-22
Abstract: A button cell having an air cathode characterized by having a cathode can 21 with air access port 16 in an essentially flat bottom 23. Air cathode 29 is positioned with its hydrophobic portion 28 abutting flat bottom 23 and grooves 25 or 25a are provided in the central portion of the interior of bottom 23 of cathode can 21 or in abutting hydrophobic portion 28 of air cathode 29 respectively.
[EP0129881A1]
Patent IE-60898-B1 (IE)
Title: Varicella-zoster virus as a live recombinant vaccine
IPC: C12N15/86
Filed: 1987-06-19
Abstract: A vaccine strain of varicella-zoster virus (VZV), tested in clinical trials, is capable of preventing chickenpox in children. This virus has been modified by the introduction into its genome of heterologous DNA which encodes an immunogenic polypeptide of another human pathogen. This heterologous polypeptide is expressed in cells infected by the recombinant virus. Such recombinant VZV is useful as a vaccine for chickenpox as well as for heterologous pathogens.
Patent IE-43589-B1 (IE)
Title: 1-azidoalkyl imidazole derivatives and process for the production thereof
IPC: C07D233/95
Filed: 1976-08-10
Abstract: 1499969 1-Azldoalky-imidazoles G D SEARLE & CO 10 Aug 1976 [11 Aug 1975] 33312/76 Heading C2C Novel compounds (I) and their acid addition salts in which X is H or NO 2 , R is H, C 1-7 alkyl, phenyl or halophenyl and Alk is C 2-4 alkylene are prepared by reacting a compound III where Z is halogen, alkylsulphonyl or tolylsulphonyl with an alkali metal azide in a polar organic solvent. Compounds I have anti-microbial activity and are also anti-hypertensives. They form with a carrier or diluent, a pharmaceutical composition which may be administered orally parenterally or rectally.
Patent IE-38367-B1 (IE)
Title: Method of making glucose isomerase and using same to concert glucose to fructose
IPC: C12P19/24
Filed: 1973-10-10
Abstract: 1399408 Fructose; enzymatic isomerization of glucose ANHEUSER-BUSCH Ine 1 Oct 1973 [10 Oct 1972] 45746/73 Heading C2S [Also in Division C3] A process for the production of glucose isomerase involves growing a micro-organism of the genus Actinoplanes in a culture medium and recovering the enzyme therefrom (whole cells or cell-free extract). Actinoplanes missouriensis NRRL B-3342, A. philippinensis, A. armeniacus and Actinoplanes sp ATCC 23342 are particularly mentioned. Isomerization by the enzyme of D-glucose to D-fructose may take place at temperatures of 40-90‹ C., pHs in the range 5À5-9À0 and glucose concentrations greater than 0À1 M, in the presence of 0À1-9À0 mM magnesium ion or 0À05-0À6 mM cobaltous ion.
[GB1399408A]
Patent IE-61170-B1 (IE)
Title: Iron mineral supplements
Inventor: NAKEL GUNTHER MARIA
IPC: A23L1/304
Filed: 1988-07-01
Abstract: Nutritional mineral supplements comprise iron-sugar complexes, especially iron sucrate-malate. Food and beverage compositions, especially juice beverages, supplemented with these iron materials are disclosed.
Patent IE-49201-B1 (IE)
Title: Forgery-resistant film and process for forgery-resistant marking of articles
IPC: C08J3/20
Filed: 1979-11-01
Abstract: The film disclosed in the application is secure against forgeries and serves for marking articles, in particular high-quality branded goods. It is comprised of at least one transparent polyester film oriented by stretching and containing in its composition an organic dyestuff which is heat stable at temperatures above about 260 DEG C. Preferably, a laminate is used which is comprised of two films, one of which contains a different colored dyestuff than does the other.
[US4341833A]
Patent IE-61503-B1 (IE)
Title: Controlled release formulation
Inventor: HOWARD JOHN RUSSELL
IPC: A61K9/22
Filed: 1988-07-27
Abstract: A controlled release pharmaceutical formulation is provided which releases a pharmaceutical of a basic character at a controlled rate regardless of the pH of the environment, which formulation includes a basic pharmaceutical, up to about 45% by weight of a pH dependent polymer which is a salt of alginic acid, such as sodium alginate, up to about 35% by weight of a pH-independent hydrocarbon gelling agent having a viscosity of up to about 100,000 centipoises in 2% solution at 20 DEG C., binder and excipients.
Patent IE-64770-B1 (IE)
Title: Pasta preparation
Inventor: BRIMELOW CHRISTOPHER JOHN BURT
IPC: A23L7/109
Filed: 1990-07-04
Abstract: A process for the preparation of a pasta which comprises forming an uncooked, partially cooked or precooked dough which may be in the form of a dough sheet or a pasta shape, coating the dough with a mixture of egg product and an edible oil and then heating to coagulate, dry and bind the coating.
Patent IE-52530-B1 (IE)
Title: Plasma-assisted etching process
IPC: H01L21/312
Filed: 1981-10-19
Abstract: In a VLSI device fabrication process, erosion of a patterned resist layer (16, 18) during dry etching of an underlying layer (14) can significantly limit the high-resolution patterning capabilities of the process. As described herein, a protective polymer layer (60, 62) is formed and maintained only on the resist material (16, 18) while the underlying layer (14) is being etched. High etch selectivities are thereby achieved. As a consequence, very thin resist layers can be utilized in the fabrication process and very-high-resolution patterning for VLSI devices is thereby made feasible.
Patent IE-42388-B1 (IE)
Title: Process for the preparation of pinacolone
IPC: C07C45/00
Filed: 1975-12-12
Abstract: 1460705 Pinacolone BAYER AG 17 Oct 1975 [27 Dec 1974] 42633/75 Heading C2C Pinacolone (2,2-dimethyl-3-oxobutane) is prepared by mixing (1) a butene derivative selected from 2-methylbut-2-ene, of the formula 2-methylbut-1-ene, of the formula the addition products of the two said butenes, of the general formula in which X is Cl, Br, HSO 4 or H 2 PO 4 , and mixtures of any of the compounds (V), (VII) and (VIII), with an aqueous solution of an inorganic acid, said aqueous phase of the mixture containing during the entire reaction period, at least 15% by weight of acid, and, while mixing intensively, (2) formaldehyde is added thereto over the course of 0À5 to 10 hours, at a pressure between 1 and 20 bars absolute and at a temperature of between 50‹ and 200‹ C., 0À5-1À5 moles of formaldehyde being added per mole of the butene derivative, the mixture being allowed to react for a further 0À5 to 3 hours, and the pinacolone is separated off by distillation, optionally after neutralization of the acid. An emulsifier may be present as may a diluent, e.g. water or a hydrocarbon or ketone, especially pinacolone. The reaction may be operated continuously in a reaction cascade.
Patent IE-62823-B1 (IE)
Title: Refuse container dolly having integral alignment means
Inventor: DELMERICO PAUL E
IPC: B65F1/14
Filed: 1990-08-22
Abstract: A refuse container and dolly assembly are disclosed, the refuse container (2) and dolly (4) having a square rectangular transverse sectional configuration. An alignment flange (34) is provided in the top surface of the dolly, adapted to engage a registration rib (18) in the underside of the container, whereby, upon rotary connection between the dolly and an underside of the waste container, the side walls of the dolly and the waste container are brought into co-planar alignment. The dolly is mounted on castors (24).
Patent IE-63952-B1 (IE)
Title: Method for the treatment of periodontal disease by sustained delivery of a pharmaceutical agent to the crevicular pocket composition of matter therefor and apparatus for the administration thereof
Inventor: BRIZZOLARA NANCY SUSAN
IPC: A61K9/50
Filed: 1989-12-21
Abstract: Oral compositions for the local administration of a therapeutic agent to a periodontal pocket of a patient for alleviating dental disease comprise a plurality of dry, discrete microparticles each of which comprise an effective amount of at least one therapeutic agent dispersed in a matrix comprising a biocompatible and biodegradable polymer. Apparatus and methods are also provided for the dispensing of the dry microparticles to the periodontal pocket whereby they become tacky and adhere to the involved tissue so as to induce long term therapeutic benefits.